These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31230775)

  • 1. [Infliximab].
    Goujon C; Bachelez H;
    Ann Dermatol Venereol; 2019; 146(6-7):483-486. PubMed ID: 31230775
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific single nucleotide polymorphism genotypes and association of an IL-12B polymorphism with secondary failure of infliximab therapy in Japanese psoriasis patients.
    Torii K; Morita A
    J Dermatol Sci; 2020 Aug; 99(2):135-136. PubMed ID: 32576423
    [No Abstract]   [Full Text] [Related]  

  • 3. [Methotrexate].
    Beylot-Barry M; Le Maitre M; Goujon C;
    Ann Dermatol Venereol; 2019; 146(6-7):459-465. PubMed ID: 31204126
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ixekizumab].
    Seneschal J;
    Ann Dermatol Venereol; 2019; 146(6-7):507-510. PubMed ID: 31204120
    [No Abstract]   [Full Text] [Related]  

  • 5. [Guselkumab].
    Montaudié H;
    Ann Dermatol Venereol; 2019; 146(6-7):515-519. PubMed ID: 31200928
    [No Abstract]   [Full Text] [Related]  

  • 6. [Secukinumab].
    Meunier L;
    Ann Dermatol Venereol; 2019; 146(6-7):503-506. PubMed ID: 31204124
    [No Abstract]   [Full Text] [Related]  

  • 7. [Brodalumab].
    Girard C;
    Ann Dermatol Venereol; 2019; 146(6-7):511-514. PubMed ID: 31204123
    [No Abstract]   [Full Text] [Related]  

  • 8. [Infliximab].
    Goujon C; Bachelez H
    Ann Dermatol Venereol; 2011 Dec; 138(12):839-41. PubMed ID: 22137623
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ustekinumab].
    Jullien D; Staumont-Salle D;
    Ann Dermatol Venereol; 2019; 146(6-7):497-502. PubMed ID: 31208737
    [No Abstract]   [Full Text] [Related]  

  • 10. Health-related quality-of-life improvements during 98 weeks of infliximab therapy in patients with plaque-type psoriasis in real-world practice.
    Shear NH; Hartmann M; Toledo-Bahena ME; Gilbert M; Katsambas A; Yao R; Popmihajlov Z
    Qual Life Res; 2016 Aug; 25(8):2031-40. PubMed ID: 26869477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tumor necrosis factor-α, interleukin-23 and interleukin-17A inhibitors on bodyweight and body mass index in patients with psoriasis.
    Takamura S; Takahashi A; Inoue Y; Teraki Y
    J Dermatol; 2018 Sep; 45(9):1130-1134. PubMed ID: 30004583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab for psoriasis.
    Gottlieb AB
    J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S112-7. PubMed ID: 12894134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granuloma annulare: a case treated with infliximab successfully.
    Giunta A; Chiricozzi A; Cannizzaro MV; Dattola A; Ruzzetti M; Nisticò SP; Chimenti S
    G Ital Dermatol Venereol; 2017 Apr; 152(2):193-195. PubMed ID: 28166622
    [No Abstract]   [Full Text] [Related]  

  • 14. [Reactions to infliximab infusions in dermatologic patients: consensus statement and treatment protocol. Working Group of the Grupo Español de Psoriasis de la Academia Española de Dermatología y Venereología ].
    Puig Sanz L; Sáez E; Lozano MJ; Bordas X; Carrascosa JM; Gallardo F; Luelmo J; Sánchez-Regaña M; Alsina M; García-Patos V;
    Actas Dermosifiliogr; 2009 Mar; 100(2):103-12. PubMed ID: 19445874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor (TNF) inhibitors revolutionalized therapy for both psoriasis and psoriatic arthritis. Foreword.
    Gottlieb AB
    Am J Clin Dermatol; 2014 Feb; 15 Suppl 1():S3-4. PubMed ID: 24777570
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ustekinumab].
    Ortonne JP
    Ann Dermatol Venereol; 2011 Dec; 138(12):848-50. PubMed ID: 22137626
    [No Abstract]   [Full Text] [Related]  

  • 17. Programmed cell death of keratinocytes in infliximab-treated plaque-type psoriasis.
    Krüger-Krasagakis S; Galanopoulos VK; Giannikaki L; Stefanidou M; Tosca AD
    Br J Dermatol; 2006 Mar; 154(3):460-6. PubMed ID: 16445776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of psoriasis: focus on clinic-based management with infliximab.
    de Eusebio E; Armario-Hita JC; de Miquel VA
    Am J Clin Dermatol; 2014 Feb; 15 Suppl 1():S5-16. PubMed ID: 24777571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The biological treatments for moderate to severe plaque psoriasis].
    Thielen AM; Marazza G
    Rev Med Suisse; 2008 Apr; 4(155):1089-90, 1092-4. PubMed ID: 18610721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risankizumab (Skyrizi) for psoriasis.
    Med Lett Drugs Ther; 2019 Jun; 61(1573):81-83. PubMed ID: 31170118
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.